Biotechnology News

Collaboration leverages Atavistik Bio’s proprietary AMPSTM platform to identify and advance novel allosteric small molecules against multiple targets for cardiometabolic diseasesAtavistik Bio to...

FDA clearance expands development of forazapadin into a second degenerative muscle disease with significant unmet medical needFSHD Canada Foundation to provide up to US$5 million in non-dilutive...

Velinotamig (BCMA TCE) multi-dose regimen data in SLE at ACR Convergence 2026 in November  CLN-978 (CD19 TCE) multi-dose regimen data in SLE, RA and Sjögren’s disease in December CLN-049 (FLT3 TCE)...

LA JOLLA, Calif., Sept. 24, 2026 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV) and the Standard Market of the Tokyo Stock...

LOUISVILLE, Colo., Sept. 24, 2026 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostics solutions company, today announced strategic progress in two collaborative programs for...

Ona Therapeutics advances ONA-255 through Phase 1a and appoints leading oncologist Aleix Prat, MD, PhD as CMO to support its next-generation ADC pipeline.

Flen Health selects AGC Biologics' Heidelberg site for GMP manufacturing of recombinant enzymes supporting U.S. clinical trials in wound care.

德国海德堡, Sept. 24, 2026 (GLOBE NEWSWIRE) -- 比利时生物制药公司 Flen Health 已选择 AGC Biologics 作为 CDMO 合作伙伴，为一款全新改良的伤口及皮肤愈合产品，提供工艺开发、放大和 GMP 生产服务。 生产服务助力监管申报与临床试验 随着 myBIOS 完成细胞系开发，AGC Biologics...

HEIDELBERG, Jerman, Sept. 24, 2026 (GLOBE NEWSWIRE) -- Flen Health, sebuah syarikat biofarmaseutikal dari Belgium, telah melantik AGC Biologics sebagai rakan CDMO strategik mereka. Kerjasama ini...

德國海德堡, Sept. 24, 2026 (GLOBE NEWSWIRE) -- 比利時生物製藥公司 Flen Health 已選定 AGC Biologics 為其 CDMO 合作夥伴，為一款全新改良的傷口及皮膚癒合產品提供製程開發、製程放大及 GMP 生產服務。 製造服務支援監管申請、臨床試驗 隨着 myBIOS 完成細胞株開發，AGC Biologics...